Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Pressure BioSciences and Sage-N Research to Collaborate

Published: Thursday, March 22, 2012
Last Updated: Thursday, March 22, 2012
Bookmark and Share
Packaging PBI's sample preparation system with Sage-N's software tools will allow mass spectrometry laboratories better access and support to these enabling technologies.

Pressure BioSciences, Inc. and Sage-N Research, Inc. have announced a collaboration to develop software applications on Sage-N's SORCERER™ Integrated Data Appliance platform.

The new software will be designed to work with PBI's patented and enabling pressure cycling technology ("PCT") system, a novel technology platform that is used to extract, among other biomolecules, integral cell membrane and other proteins for subsequent mass spectrometry analysis.

Integral cell membrane proteins are of significant clinical importance due to their roles in cell signal transduction in cancer, membrane transport disorders like Crohn's disease, pathogen invasion such as HIV, and their roles in other diseases and disorders.

Unfortunately, integral cell membrane proteins are traditionally very difficult to extract. In some cases, harsh chemicals are used in the extraction process, causing such severe protein degradation that subsequent proteomic analysis is compromised.

PBI's PCT Platform uses rapid cycles of low and ultra-high pressure to safely and effectively extract proteins from samples (including cell membranes) that are suitable for analysis by analytical methods such as mass spectrometry.

The PCT Platform also provides a high level of automation, speed, and reproducibility in the enzymatic breakdown of proteins. This allows the PCT-enhanced digestion to be completed in under an hour, compared to the standard four to twelve hours.

Richard T. Schumacher, President and CEO of PBI, said: "We plan to seamlessly integrate PBI's front- end PCT Sample Preparation System (instruments and consumables) with Sage-N's SORCERER back- end data reduction software. We expect to offer this bundled platform as an option to stand-alone sample preparation and data reduction methods used currently by the mass spectrometry laboratory. We believe that by bundling these enabling platforms, we will be offering a higher quality, more efficient, and less costly solution than they currently have for sample preparation and data reduction. Since the companies now target an identical market - the mass spectrometry laboratory - we expect to share a number of marketing and selling programs directed at this market going forward. Overall, we believe our new co- marketing program will reduce costs and increase sales for both PBI and Sage-N before the end of 2012."

"Mass spectrometry proteomics continues to evolve from a general-purpose protein identification technology to specialized applications, such as characterization of membrane proteins and detecting novel pathogens," noted David Chiang, Chairman of Sage-N Research.

Chiang continued, "Our SORCERER platform continues to evolve to meet the ever expanding IT needs of mass spectrometry labs by providing advanced companion tools for these applications."

Sage-N Research's SORCERER Integrated Data Appliance platform provides complementary software applications that are customized for each particular sample preparation chemistry.

This results in a semi- automated system for membrane and other protein analysis that can use any modern tandem mass spectrometer and liquid chromatography system.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sage-N Research Gains Rights to Sell SEQUEST Proteomic Search Engine
Sage-N will develop and sell products based on the proteomic search software, which was licensed to Thermo Fisher by the University of Washington.
Tuesday, May 15, 2007
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos